Ticker Details
Cytokinetics, Incorporated Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
IPO Date:	May 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 2.80%
Avg Daily Range (30 D):	$1.26 | 1.96%
Avg Daily Range (90 D):	$1.32 | 2.10%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	1.41M
Avg Daily Volume (90 D):	1.55M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	8,117
Avg Institutional Trade:	$3.34M
Avg Institutional Trade (30 D):	$4.05M
Avg Institutional Trade (90 D):	$4.25M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.16M
Avg Closing Trade (30 D):	$13.77M
Avg Closing Trade (90 D):	$14.03M
Avg Closing Volume:	176.77K

News

Feb 24, 2026 @ 9:00 PM Cytokinetics Reports Fourth Quarter 2025 Financial... Source: Cytokinetics, Incorporated

Feb 19, 2026 @ 8:30 AM Global Amyotrophic Lateral Sclerosis Therapeutics ... Source: Custom Market Insights

Feb 12, 2026 @ 9:00 PM Cytokinetics to Announce Fourth Quarter Results on... Source: Na

Jan 20, 2026 @ 9:00 PM Cytokinetics Announces Inducement Grants Under Nas... Source: Na

Jan 5, 2026 @ 9:00 PM Cytokinetics to Present at the 44th Annual J.P. Mo... Source: Na

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-2.55	$-1.12
Diluted EPS		$-2.55	$-1.12
Revenue		$1.94M	$66.77M
Gross Profit
Net Income / Loss		$-306.18M	$-134.37M
Operating Income / Loss		$-166.76M	$-111.51M
Cost of Revenue
Net Cash Flow		$152.03M	$2.5M
PE Ratio

Splits
Jun 25, 2013	1:6